谷胱甘肽介导的抗癌铂（IV）配合物的活化 - Suppr

Suppr

超能文献

Glutathione-mediated activation of anticancer platinum(IV) complexes.

作者信息

Eastman A

机构信息

Eppley Institute for Research in Cancer, University of Nebraska Medical Center, Omaha 68105.

出版信息

Biochem Pharmacol. 1987 Dec 1;36(23):4177-8. doi: 10.1016/0006-2952(87)90581-8.

DOI:10.1016/0006-2952(87)90581-8

PMID:3689445

Abstract

摘要

相似文献

Glutathione-mediated activation of anticancer platinum(IV) complexes.谷胱甘肽介导的抗癌铂（IV）配合物的活化

Biochem Pharmacol. 1987 Dec 1;36(23):4177-8. doi: 10.1016/0006-2952(87)90581-8.

Glutathione-mediated modulation of tetraplatin activity against sensitive and resistant tumor cells.谷胱甘肽介导的四铂对敏感和耐药肿瘤细胞活性的调节作用。

Biochem Pharmacol. 1994 Apr 29;47(9):1635-42. doi: 10.1016/0006-2952(94)90542-8.

Modulation of cytotoxicity and cellular pharmacology of 1,2-diaminocyclohexane platinum (IV) complexes mediated by axial and equatorial ligands.轴向和赤道配体介导的1,2-二氨基环己烷铂（IV）配合物的细胞毒性和细胞药理学调节

Cancer Res. 1993 Oct 1;53(19):4567-72.

Glutathione-associated cis-diamminedichloroplatinum(II) metabolism and ATP-dependent efflux from leukemia cells. Molecular characterization of glutathione-platinum complex and its biological significance.谷胱甘肽相关的顺二氯二氨铂（II）代谢及白血病细胞中ATP依赖的外排。谷胱甘肽-铂复合物的分子特征及其生物学意义。

J Biol Chem. 1993 Sep 25;268(27):20116-25.

Role of carrier ligand in platinum resistance in L1210 cells.载体配体在L1210细胞铂耐药中的作用。

Cancer Res. 1990 Oct 15;50(20):6497-501.

Evaluation of novel ammine/amine platinum (IV) dicarboxylates in L1210 murine leukaemia cells sensitive and resistant to cisplatin, tetraplatin or carboplatin.新型氨/胺铂（IV）二羧酸盐在对顺铂、四铂或卡铂敏感及耐药的L1210小鼠白血病细胞中的评估

Br J Cancer. 1994 Sep;70(3):415-20. doi: 10.1038/bjc.1994.320.

The role of metallothionein, glutathione, glutathione S-transferases and DNA repair in resistance to platinum drugs in a series of L1210 cell lines made resistant to anticancer platinum agents.金属硫蛋白、谷胱甘肽、谷胱甘肽S-转移酶和DNA修复在一系列对抗癌铂类药物产生抗性的L1210细胞系中对铂类药物抗性方面的作用。

Biochem Pharmacol. 1993 Jan 7;45(1):253-6. doi: 10.1016/0006-2952(93)90399-h.

Biochemical pharmacology of homologous alicyclic mixed amine platinum(II) complexes in sensitive and resistant tumor cell lines.同源脂环族混合胺铂（II）配合物在敏感和耐药肿瘤细胞系中的生化药理学

Cancer Res. 1994 Jul 1;54(13):3468-73.

Role of DNA replication in carrier-ligand-specific resistance to platinum compounds in L1210 cells.DNA复制在L1210细胞对铂化合物的载体-配体特异性抗性中的作用。

Carcinogenesis. 1991 Dec;12(12):2253-7. doi: 10.1093/carcin/12.12.2253.

A novel trans-platinum coordination complex possessing in vitro and in vivo antitumor activity.一种具有体外和体内抗肿瘤活性的新型反式铂配位络合物。

Cancer Res. 1994 Nov 1;54(21):5618-22.

引用本文的文献

Development of Novel Pt(IV)-Carbohydrate Derivatives as Targeted Anticancer Agents against Osteosarcoma.新型 Pt(IV)-碳水化合物衍生物作为针对骨肉瘤的靶向抗癌药物的研发。

Int J Mol Sci. 2023 Mar 23;24(7):6028. doi: 10.3390/ijms24076028.

Natural products as a means of overcoming cisplatin chemoresistance in bladder cancer.天然产物作为克服膀胱癌顺铂化疗耐药性的一种手段。

Cancer Drug Resist. 2021 Mar 19;4(1):69-84. doi: 10.20517/cdr.2020.69. eCollection 2021.

Comparison of the effects of the oral anticancer platinum(IV) complexes oxoplatin and metabolite cis-diammine-tetrachlorido-platinum(IV) on global gene expression of NCI-H526 cells.口服抗癌铂（IV）配合物奥沙铂及其代谢产物顺二氨基四氯铂（IV）对NCI-H526细胞全局基因表达影响的比较。

J Exp Pharmacol. 2011 Apr 1;3:43-50. doi: 10.2147/JEP.S13630. eCollection 2011.

Redox activation of metal-based prodrugs as a strategy for drug delivery.基于氧化还原的金属前药激活策略用于药物递送。

Adv Drug Deliv Rev. 2012 Aug;64(11):993-1004. doi: 10.1016/j.addr.2012.01.007. Epub 2012 Jan 25.

Anticancer activity of metal complexes: involvement of redox processes.金属配合物的抗癌活性：氧化还原过程的参与。

Antioxid Redox Signal. 2011 Aug 15;15(4):1085-127. doi: 10.1089/ars.2010.3663. Epub 2011 May 11.

In Vitro Evaluation of Oxoplatin: An Oral Platinum(IV) Anticancer Agent.奥沙铂的体外评价：一种口服铂（IV）类抗癌剂。

Met Based Drugs. 2009;2009:348916. doi: 10.1155/2009/348916. Epub 2009 Jun 30.

Unusual DNA binding modes for metal anticancer complexes.金属抗癌配合物的异常DNA结合模式。

Biochimie. 2009 Oct;91(10):1198-211. doi: 10.1016/j.biochi.2009.03.017. Epub 2009 Apr 1.

Kinetics and mechanism for reduction of anticancer-active tetrachloroam(m)ine platinum(IV) compounds by glutathione.谷胱甘肽还原抗癌活性四氯氨（亚）铂（IV）化合物的动力学及机制

J Biol Inorg Chem. 2000 Jun;5(3):300-6. doi: 10.1007/pl00010658.

Phase I clinical and pharmacokinetic study of an one-hour infusion of ormaplatin (NSC 363812).奥马铂（NSC 363812）一小时输注的I期临床和药代动力学研究。

Invest New Drugs. 1999;17(1):63-72. doi: 10.1023/a:1006223100561.

Stereoselective peripheral sensory neurotoxicity of diaminocyclohexane platinum enantiomers related to ormaplatin and oxaliplatin.与奥马铂和奥沙利铂相关的二氨基环己烷铂对映体的立体选择性外周感觉神经毒性。

Br J Cancer. 1997;76(4):502-10. doi: 10.1038/bjc.1997.416.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验